Bibliography
- MacFarlane RJ, Ng BH, Gamie Z, Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opin Pharmacother 2008;9:1-14
- Glaser DL, Economides AN, Wang L, In vivo somatic gene transfer of an engineered Noggin mutein prevents BMP-4 induced heterotopic ossification. J Bone Joint Surg Am 2003;85(12):2332-42
- Pavlou G, Salhab M, Murugesan L, Heterotopic Ossification: analysis of risk factors in 920 primary hip arthroplasties. Hip Int 2012; In Press
- Pakos EE, Stafilas KS, Tsekeris PG, Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty. Strahlenther Onkol 2009;185(8):500-5
- Le Duff MJ, Takamura KB, Amstutz HC. Incidence of heterotopic ossification and effects of various prophylactic methods after hip resurfacing. Bull NYU Hosp Jt Dis 2011;69:S36-41
- Weber EW, Slappendel R, Durieux ME, COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 2003;20:963-6
- Saudan M, Saudan P, Perneger T, Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg Br 2007;89:155-9
- Bombardier C, Laine L, Reicin A, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group. N Engl J Med 2000;343(21):1520-8
- Grohs JG, Schmidt M, Wanivenhaus A. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop 2007;78:95-8
- Neal BC, Rogers A, Gray H, No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2649 patients. Acta Orthop Scand 2000;71:129-34
- Bek D, Beksac B, Della Valle AG, Aspirin decreases the prevalence and severity of heterotopic ossification after 1-stage bilateral total hip arthroplasty for osteoarthrosis. J Arthroplasty 2009;24(2):226-32
- Nunley RM, Zhu J, Clohisy JC, Aspirin decreases heterotopic ossification after hip resurfacing. Clin Orthop Relat Res 2011;469:1614-20
- Yu PB, Deng DY, Lai CS, BMP type 1 receptor inhibition reduced heterotopic ossification. Nat Med 2008;14(12):1363-9
- Hanallah D, Pong H, Young B, Retro-viral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am 2004;86:80-91
- Shimono K, Tung W, Macolino C, Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor gamma agonists. Nat Med 2011;17(4):454-60
- Vanden Bossche LC, Van Maele G, Wojtowicz I, Free radical scavengers are more effective than indomethacin in the prevention of experimentally induced heterotopic ossification. J Orthop Res 2007;25(2):267-72
- Vanden Bossche LC, Van Maele G, Woitowicz I, Free radical scavengers versus methylprednisolone in the prevention of experimentally induced heterotopic ossification. J Orthop Res 2009;27(6):748-51
- Haran MJ, Bhuta T, Lee BS. WITHDRAWN: Pharmacological interventions for treating acute heterotopic ossification. Cochrane Database Syst Rev 2010;12(5):CD003321